Announced
Completed
Synopsis
Ampersand Capital, a private equity firm, completed the acquisition of Specac, a spectroscopy accessories and sample prep solutions manufacturer, from Foresight Group, a listed infrastructure and regional private equity investment manager. Financial terms were not disclosed. “We are thrilled to partner with the entire Specac team. Ampersand’s expertise in accelerating growth-minded life sciences-oriented lab products organizations make them an excellent fit. Under Shannon’s leadership, Specac is poised for continued success delivering customer-focused solutions, exceptional quality, and superior service via its talented specialists,” David Patteson, Ampersand Partner.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.